StandardStandard

Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. / Orgeta, V.; Leung, P.; Yates, L. et al.
Yn: Health Technology Assessment, Cyfrol 19, Rhif 64, 01.08.2015.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Orgeta, V, Leung, P, Yates, L, Kang, S, Hoare, ZS, Henderson, C, Whitaker, C, Burns, A, Knapp, M, Leroi, I, Moniz-Cook, ED, Pearson, S, Simpson, S, Spector, A, Roberts, S, Russell, IT, de Waal, H, Woods, RT & Orrell, M 2015, 'Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial', Health Technology Assessment, cyfrol. 19, rhif 64. https://doi.org/10.3310/hta19640

APA

Orgeta, V., Leung, P., Yates, L., Kang, S., Hoare, Z. S., Henderson, C., Whitaker, C., Burns, A., Knapp, M., Leroi, I., Moniz-Cook, E. D., Pearson, S., Simpson, S., Spector, A., Roberts, S., Russell, I. T., de Waal, H., Woods, R. T., & Orrell, M. (2015). Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. Health Technology Assessment, 19(64). https://doi.org/10.3310/hta19640

CBE

Orgeta V, Leung P, Yates L, Kang S, Hoare ZS, Henderson C, Whitaker C, Burns A, Knapp M, Leroi I, et al. 2015. Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. Health Technology Assessment. 19(64). https://doi.org/10.3310/hta19640

MLA

VancouverVancouver

Orgeta V, Leung P, Yates L, Kang S, Hoare ZS, Henderson C et al. Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. Health Technology Assessment. 2015 Awst 1;19(64). doi: 10.3310/hta19640

Author

Orgeta, V. ; Leung, P. ; Yates, L. et al. / Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. Yn: Health Technology Assessment. 2015 ; Cyfrol 19, Rhif 64.

RIS

TY - JOUR

T1 - Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial

AU - Orgeta, V.

AU - Leung, P.

AU - Yates, L.

AU - Kang, S.

AU - Hoare, Z.S.

AU - Henderson, C.

AU - Whitaker, C.

AU - Burns, A.

AU - Knapp, M.

AU - Leroi, I.

AU - Moniz-Cook, E.D.

AU - Pearson, S.

AU - Simpson, S.

AU - Spector, A.

AU - Roberts, S.

AU - Russell, I.T.

AU - de Waal, H.

AU - Woods, R.T.

AU - Orrell, M.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Cognitive stimulation approaches can improve cognition and quality of life for people with dementia but little is known about whether cognitive stimulation interventions led by carers are effective. This study used qualitative methods, professional expert feedback and a field-testing study to develop a home-based individual cognitive stimulation therapy (iCST) programme for people with dementia using the established group cognitive stimulation therapy approach. The carer-led intervention was tested using a randomised controlled trial design to evaluate whether iCST benefits cognition and quality of life for people with dementia, and mental and physical health for carers. We followed participants for 13 weeks and 26 weeks. People with dementia receiving iCST did not benefit in terms of cognition at either time point. There was no evidence that iCST improved quality of life for people with dementia or carers’ mental or physical health. People with dementia engaging in iCST reported a better relationship quality with their family carer at 26 weeks. Carers taking part in iCST with their relative experienced better health-related quality of life at 26 weeks. Despite evidence of improvements in the caregiving relationship for people with dementia and health-related quality of life for carers, this study provides no evidence that carer-led cognitive stimulation interventions help cognition or quality of life for people with dementia. Further research is needed to evaluate the impact of carer-led cognitive-based interventions for people with dementia.

AB - Cognitive stimulation approaches can improve cognition and quality of life for people with dementia but little is known about whether cognitive stimulation interventions led by carers are effective. This study used qualitative methods, professional expert feedback and a field-testing study to develop a home-based individual cognitive stimulation therapy (iCST) programme for people with dementia using the established group cognitive stimulation therapy approach. The carer-led intervention was tested using a randomised controlled trial design to evaluate whether iCST benefits cognition and quality of life for people with dementia, and mental and physical health for carers. We followed participants for 13 weeks and 26 weeks. People with dementia receiving iCST did not benefit in terms of cognition at either time point. There was no evidence that iCST improved quality of life for people with dementia or carers’ mental or physical health. People with dementia engaging in iCST reported a better relationship quality with their family carer at 26 weeks. Carers taking part in iCST with their relative experienced better health-related quality of life at 26 weeks. Despite evidence of improvements in the caregiving relationship for people with dementia and health-related quality of life for carers, this study provides no evidence that carer-led cognitive stimulation interventions help cognition or quality of life for people with dementia. Further research is needed to evaluate the impact of carer-led cognitive-based interventions for people with dementia.

U2 - 10.3310/hta19640

DO - 10.3310/hta19640

M3 - Article

VL - 19

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 64

ER -